PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsHyperparathyroidism
MeSH D006961 - hyperparathyroidism
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D010279:Parathyroid diseases
0 Companies
0 Drugs
Success rate
D006961: 
Hyperparathyroidism
32 Companies
4 Drugs
$
Success rate
D006962:Secondary hyperparathyroidism
16 Companies
2 Drugs
$
Success rate
D049950:Primary hyperparathyroidism
15 Companies
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCalcitriol Calcitriol  2001-10-12   
Paricalcitol Paricalcitol  2013-09-27   
SandozParicalcitol Paricalcitol  2011-07-27   
AbbVieCalcitriol Calcijex  1986-09-25   
Paricalcitol Zemplar  1998-04-17 $379 M Q3/12-Q3/13 
Aurobindo PharmaParicalcitol Paricalcitol  2016-01-14   
Dr Reddys LaboratoriesParicalcitol Paricalcitol  2014-06-24   
Rising PharmaceuticalsParicalcitol Paricalcitol  2014-06-24   
Calcitriol Calcitriol  2018-11-21   
Sun Pharmaceutical IndustriesCalcitriol Calcitriol  2019-02-21   
Marksans PharmaParicalcitol Paricalcitol  2016-10-07   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
80%
4/5
Phase 2
0%
0/4
Phase 3
86%
6/7
Approved: 4Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Calcitriol
AbbVie
Paricalcitol
Sanofi
Doxercalciferol,
Calcium carbonate,
Sodium lactate,
Microcrystalline cellulose
Dr Reddys Laboratories
Paricalcitol
1
2
3
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use